Abstract:Cataract formation is the leading cause of blindness across the globe. The eye lens is the onset site of cataract. The eye lens is densely packed with crystallins at a high concentration. Crystallins are categorized into 3 distinct families: alpha-, beta-, and gamma-CRYs. The alpha-CRYs are known to function as a small molecule chaperone, recognizing misfolded proteins and maintaining protein homeostasis in the lens. While the beta-/gamma-CRYs serve a key structural role in lens formation through intramolecular and intermolecular interactions. Crystallins are arranged in transiently short-range order within the lens fibers. In addition, the molecular recognition and dynamic protein interactions that are medicated by crystallins serve a critical role in maintaining the transparency of the eye lens. Protein homeostasis disorder in eye lens is the main pathogenic factors causing cataract. The crystallins have a long half-life and no longer renewed after protein synthesis. Therefore, the crystallins are highly susceptible to both the extracellular and intracellular factors, such as pH, metal ions, radiation damage and post-translational modifications. These factors disrupt molecular recognition of the crystallins or alter protein-protein interactions, resulting in cataract formation. Identifying the chemical regulatory principles of molecular recognition and protein interactions of the crystallins can help elucidate the molecular mechanisms that maintain or disrupt lens transparency, along with developing innovative treatment strategies for cataract. In this review, based on recent prowess in crystallins and cataracts, we comprehensively summarized the way of molecular recognition and protein interaction in the crystallins, as well as the regulatory factors. Recent technological innovations that were enabling us to characterize interactions between the crystallins were further discussed. In addition, we investigated the application values and challenges of protein-protein interaction networks that were dominated by the crystallins in the anti-cataract drug development.

Progress on pathogenesis, prevention and treatment of cataract

Research Progress of Molecular Recognition and Interaction of Crystallins Linking Cataract

Research progress on antioxidants and protein aggregation inhibitors in cataract prevention and therapy (Review)

Cataract formation and prevention

Advances in pathogenesis and pharmacotherapy of cataract

Advances in drug therapy and delivery for cataract treatment

Advances in Pharmacotherapy of Cataracts

Research Progress in Major Intrinsic Protein Genes of Congenital Cataract

Oxidative stress and antioxidants in cataract development

Current Trends in the Pharmacotherapy of Cataracts

Through the Cat-Map Gateway: A Brief History of Cataract Genetics

Research progress on the correlation between cataract occurrence and nutrition

Reactive Oxygen Species and Eye Aging in Cataracts through Biomolecular Mechanisms

[Protein Post-Translational Modification and Age-Related Cataract].

Increasing Susceptibility to Oxidative Stress by Cataract-Causing Crystallin Mutations

Recent Progression of Pathogenesis and Treatment for Diabetic Cataracts

Inherited cataracts: molecular genetics, clinical features, disease mechanisms and novel therapeutic approaches

Recent progress and research trend of anti-cataract pharmacology therapy: A bibliometric analysis and literature review

Advances in the study of drug -induced cataract and its pathogenesis

Pharmacological chaperone for α-crystallin partially restores transparency in cataract models

Oxidative Stress in Cataract Formation: Is There a Treatment Approach on the Horizon?